glp-1 lemme | The first production support supplement of its kind ๐งฌ Formulated with 3 clinically-studied ingredients, Lemme GLP-1 Daily supports Lemme GLP-1 Daily (NOT SPONSORED)
Description
Beyond lowering A1C levels, these drugs support cardiovascular health and reduce body weight
In the study, people taking semaglutide drugs reported reduced urges to drink and fewer heavy drinking episodes
What sets us apart: Expertise : Our licensed providers are trained in metabolic medicine, hormone therapy, and functional health
FDA approved a new indication for semaglutide (Wegovy) to reduce the risk of cardiovascular death, myocardial infarction, and stroke in adults with CVD and either obesity or overweight (Lincoff et al., 2023)
